• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM8 通过调节 p53 活性来决定细胞周期停滞。

TRIM8 modulates p53 activity to dictate cell cycle arrest.

机构信息

Institute for Biomedical Technologies, National Research Council, Bari, Italy.

出版信息

Cell Cycle. 2012 Feb 1;11(3):511-23. doi: 10.4161/cc.11.3.19008.

DOI:10.4161/cc.11.3.19008
PMID:22262183
Abstract

p53 is a central hub in controlling cell proliferation. To maintain genome integrity in response to cellular stress, p53 directly regulates the transcription of genes involved in cell cycle arrest, DNA repair, apoptosis and/or senescence. An array of post-translational modifications and protein-protein interactions modulates its stability and activities in order to avoid malignant transformation. However, to date it is still not clear how cells decide their own fate in response to different types of stress. We described here that the human TRIM8 protein, a member of the TRIM family, is a new modulator of the p53-mediated tumor suppression mechanism. We showed that under stress conditions, such as UV exposure, p53 induced the expression of TRIM8, which in turn stabilized p53 leading to cell cycle arrest and reduction of cell proliferation through enhancement of CDKN1A (p21) and GADD45 expression. TRIM8 silencing reduced the capacity of p53 to activate genes involved in cell cycle arrest and DNA repair, in response to cellular stress. Concurrently, TRIM8 overexpression induced the degradation of the MDM2 protein, the principal regulator of p53 stability. Co-immunoprecipitation experiments showed that TRIM8 physically interacted with p53, impairing its interaction with MDM2. Altogether, our results reveal a previously unknown regulatory pathway controlling p53 activity and suggest TRIM8 as a novel therapeutic target to enhance p53 tumor suppressor activity.

摘要

p53 是控制细胞增殖的中心枢纽。为了响应细胞应激,维持基因组完整性,p53 直接调节参与细胞周期阻滞、DNA 修复、细胞凋亡和/或衰老的基因的转录。一系列翻译后修饰和蛋白-蛋白相互作用调节其稳定性和活性,以避免恶性转化。然而,到目前为止,细胞如何响应不同类型的应激来决定自身命运仍不清楚。我们在这里描述了人类 TRIM8 蛋白,一种 TRIM 家族的成员,是 p53 介导的肿瘤抑制机制的新调节剂。我们表明,在应激条件下,如 UV 暴露,p53 诱导 TRIM8 的表达,TRIM8 反过来稳定 p53,导致细胞周期阻滞和细胞增殖减少,通过增强 CDKN1A(p21)和 GADD45 的表达。TRIM8 沉默降低了 p53 激活细胞周期阻滞和 DNA 修复相关基因的能力,以响应细胞应激。同时,TRIM8 过表达诱导 MDM2 蛋白的降解,MDM2 是 p53 稳定性的主要调节因子。共免疫沉淀实验表明,TRIM8 与 p53 物理相互作用,破坏其与 MDM2 的相互作用。总之,我们的结果揭示了一个以前未知的调节途径,控制 p53 活性,并提示 TRIM8 是增强 p53 肿瘤抑制活性的新的治疗靶点。

相似文献

1
TRIM8 modulates p53 activity to dictate cell cycle arrest.TRIM8 通过调节 p53 活性来决定细胞周期停滞。
Cell Cycle. 2012 Feb 1;11(3):511-23. doi: 10.4161/cc.11.3.19008.
2
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.TRIM8通过抑制化疗耐药肿瘤中的N-MYC活性来恢复p53肿瘤抑制功能。
Mol Cancer. 2017 Mar 21;16(1):67. doi: 10.1186/s12943-017-0634-7.
3
Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.Mdm2是p21抑制Cdk2活性所必需的,从而有助于p53依赖的细胞周期停滞。
Mol Cell Biol. 2007 Jun;27(11):4166-78. doi: 10.1128/MCB.01967-06. Epub 2007 Mar 19.
4
The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.组蛋白乙酰转移酶 PCAF 通过应激诱导的组蛋白 H3 乙酰化调节 p21 转录。
Cell Cycle. 2012 Jul 1;11(13):2458-66. doi: 10.4161/cc.20864.
5
A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation.一项遗传筛选确定 TCF3/E2A 和 TRIAP1 为细胞对 p53 激活反应的特定途径调节因子。
Cell Rep. 2013 May 30;3(5):1346-54. doi: 10.1016/j.celrep.2013.04.014. Epub 2013 May 16.
6
XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.XAF1通过激活HIPK2和ZNF313来引导p53信号通路的凋亡转换。
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15532-7. doi: 10.1073/pnas.1411746111. Epub 2014 Oct 13.
7
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.一种特定的MDM2拮抗剂(MI-43)使p53重新激活,导致p21介导的细胞周期停滞以及结肠癌中的选择性细胞死亡。
Mol Cancer Ther. 2008 Jun;7(6):1533-42. doi: 10.1158/1535-7163.MCT-08-0140.
8
TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.TRIM8对化疗耐药性肾细胞癌的抗增殖作用。
Oncotarget. 2014 Sep 15;5(17):7446-57. doi: 10.18632/oncotarget.2081.
9
p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.人痘苗病毒相关激酶1诱导的p53稳定化与积累
Mol Cell Biol. 2004 Dec;24(23):10366-80. doi: 10.1128/MCB.24.23.10366-10380.2004.
10
Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.磷酸化热休克蛋白 27 激活 ATM 依赖性 p53 信号通路并介导 MCF-7 细胞对阿霉素诱导的细胞凋亡的抵抗。
Cell Signal. 2013 May;25(5):1176-85. doi: 10.1016/j.cellsig.2013.01.017. Epub 2013 Jan 26.

引用本文的文献

1
E3 ligase TRIM8 suppresses lung cancer metastasis by targeting MYOF degradation through K48-linked polyubiquitination.E3泛素连接酶TRIM8通过K48连接的多聚泛素化靶向降解MYOF来抑制肺癌转移。
Cell Death Dis. 2025 Feb 11;16(1):88. doi: 10.1038/s41419-025-07421-6.
2
Exploring the Mechanisms, Biomarkers, and Therapeutic Targets of TRIM Family in Gastrointestinal Cancer.探索TRIM家族在胃肠道癌中的作用机制、生物标志物及治疗靶点
Drug Des Devel Ther. 2024 Dec 5;18:5615-5639. doi: 10.2147/DDDT.S482340. eCollection 2024.
3
Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α.
三结构域蛋白 8 通过介导 HNF1α 的泛素化促进肝细胞癌的进展。
Cell Death Dis. 2024 Jun 15;15(6):416. doi: 10.1038/s41419-024-06819-y.
4
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.错综复杂的对抗:TRIM 家族蛋白在肿瘤免疫逃逸中的研究进展与应用潜力。
J Adv Res. 2023 Dec;54:147-179. doi: 10.1016/j.jare.2023.01.011. Epub 2023 Feb 2.
5
TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt.TRIM8:胶质母细胞瘤的双刃剑,既能治愈也能伤害。
Cell Mol Biol Lett. 2023 Jan 23;28(1):6. doi: 10.1186/s11658-023-00418-z.
6
Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules.寻找高级别浆液性卵巢癌发病机制中的新参与者,其有潜力用作诊断分子。
Life (Basel). 2022 Dec 3;12(12):2017. doi: 10.3390/life12122017.
7
The Underestimated Role of the p53 Pathway in Renal Cancer.p53通路在肾癌中被低估的作用
Cancers (Basel). 2022 Nov 22;14(23):5733. doi: 10.3390/cancers14235733.
8
Identification and validation of novel biomarker TRIM8 related to cervical cancer.与宫颈癌相关的新型生物标志物TRIM8的鉴定与验证
Front Oncol. 2022 Oct 24;12:1002040. doi: 10.3389/fonc.2022.1002040. eCollection 2022.
9
TRIM family contribute to tumorigenesis, cancer development, and drug resistance.TRIM家族参与肿瘤发生、癌症发展和耐药过程。
Exp Hematol Oncol. 2022 Oct 19;11(1):75. doi: 10.1186/s40164-022-00322-w.
10
Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis.剖析TRIM8蛋白在癌症发病机制中的功能作用。
Cancers (Basel). 2022 May 6;14(9):2309. doi: 10.3390/cancers14092309.